A Substudy of the CADRE Study: Determination of Clinical Markers in Patients With Extreme Sickle Cell Disease Phenotype

Study point of contact

Brigitte Ranque, MD
0156092772
[email protected]

Locations

1 Mali site

1 Senegal site

Age

> 10 Years

Study type

Observational

Gender

All

Interventions

Biological

Other

Compensation

Unknown

About the study

BIOCADRE is a CADRE substudy and aims to characterize more precisely the sickle cell patients
with extreme phenotype.

participation requirements

– sickle cell patients with extreme phenotypes: SS-hemoglobin

participation restrictions

– transfusion in the previous 2 months

– vaso-occlusive crisis in the previous 15 days

– infection in the previous 8 days

Locations

  • Bamako, Mali, Centre de Recherches er de Lutte contre la Dr√©panocytose [Recruiting]
  • Dakar, Senegal, Centre National de Transfusion Sanguine [Recruiting]